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ABSTRACT 
Objective: The objective of present study was to evaluate the anti-inflammatory activity of ethanolic extract of Bauhinia variegate root. 
Methods: In the present study BVEE at 200 and 400 mg/kg body weight was studied for anti-inflammatory activities in different animal models.. 
Anti- inflammatory activity was carried out by using carrageenan induced paw edema model and cotton pellet induced granuloma model in wistar 
rats. 
Results: The results shows that BVEE possess anti-inflammatory activity in acute as well as sub acute models of inflammation in rats. BVEE (200 
and 400 mg/kg) showed significant (p <0.01) anti-inflammatory activity by reducing the paw edema volume in carrageenan-induced paw edema in 
rats in the late phase (2to4h)regulated by prostaglandins and leucotrienes and in cotton pellet induced granuloma model BVEE decreased dry 
weight of granuloma. 
Conclusion: The observed pharmacological activity may be due to presence of phytochemical compounds present in the extract like alkaloids, 
flavonoids, phenols, saponins and tannins.  




Pain is sensorial modality representing in many cases the only 
symptom for diagnosis of several diseases [1].While inflammation is 
a complex defensive mechanism which consists of highly sequential 
events provoked by number of stimuli like pathogens, noxious 
mechanical and chemical agents, and autoimmune responses. The 
subsequent cascade of events which takes place in inflammation is 
characterized by various signs and symptoms like redness, swelling, 
heat, and pain. A regulated response protects against further injury 
and clears damaged tissue in physiological conditions while in 
pathological condition inflammation may result in tissue destruction 
and lead to organ dysfunction [1]. All the steroidal and non steroidal 
anti-inflammatory drugs (NSAID’s) available in market cause 
undesired and serious side effects during their clinical use, so 
studies have been continuing on inflammatory diseases and the side 
effects of the currently available anti-inflammatory drugs. The 
currently used anti-inflammatory drugs may not be useful in all 
cases so there is increased focus on plant research and their active 
constituents [2]. 
Bauhinia variegata (family-Leguminosae) is a medium sized 
deciduous tree, sparingly grown in India.The plant is found in 
Throughout India, growing wild and as a garden plant. Widely 
planted in the tropics and warm regions of the world, including the 
southern margin of the United States from Florida to California. This 
plant is used traditionally in scrofula, diarrhea, anticancer, pain, 
rheumatism, delirium, and depressant[1].These active constituents 
have been attributed the therapeutic activity of the plant. Therefore, 
the present study was undertaken to evaluate their anti-
inflammatory activities. 
MATERIALS AND METHODS  
Drugs and chemicals 
Diclofenac sodium (gift sample from Microlabs) Carrageenan 
(Sigma- Aldrich, St. Louis, MO, USA), ethanol (Qualigens, Mumbai, 
India) petroleum ether (jk chemicals, Hyderabad) all reagents used 
in the experiment were of analytical grade respectively.  
Collection and authentication of plant material 
The Plant specimen for the proposed study was collected from 
Nellore, Andhra pradesh It was identified and authenticated by Dr. P. 
Jayaraman, Director, Plant Anatomy Research Center, (PARC) 
Tambaram, Chennai (PARC/ 2010/ 628). 
Preparation of extracts 
The freshly collected Root of Bauhinia variegate Linn of this plant 
was chopped, shad dried and coarsely powdered. The powder was 
defatted with petroleum ether (60-80o
Animals 
c) then successively extracted 
with ethanol (90% v/v) using soxhlet extractor. The ethanolic 
extracts were dried under reduced pressure using a rotary vacuum 
evaporator. The percentage yield was 3.912 % w/w for ethanol 
extract. 
Wistar albino rats of either sex (175-200g) were obtained from 
saastra Bioscience Research Laboratories in Saastra College of 
pharmaceutical education and research centre, Varigonda village, 
Totapalligudur Mandal, SPSR Nellore dist. Animals were housed in 
plastic cages at an ambient temperature (25±2o
Animals were acclimatized to their environment for at least one 
week before experimentation. The animals were randomly divided 
into different groups. Each animal was housed separately after 
recording its body weight and had kept separate marks for 
identifying the dose level, group and individual number. 
C) and relative 
humidity of 45-55%. A 12:12 hr light- dark cycle was maintained 
during the experiments. They were fed with balanced rodent pellet 
diet from saastra Bioscience Research Laboratories, Nellore and 
water ad libitum throughout the experimental period.  
IAEC approval The Institutional Animal Ethics Committee (IAEC) 
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approved the protocol of the study on Registration no. 1243/bc/08/ 
CPCSEA dated 9.02.2011. All animal experiments were carried out as 
per the rules and regulations of IAEC & CPCSEA (Committee for the 
Purpose of Control and Supervision of Experiments on Animals) 
under the “Guidelines for Care and Use of Animals in Scientific 
Research”. 
Preliminary phytochemical screening  
Qualitative preliminary phytochemical screening was carried out for 
evaluation of tannins, alkaloids, flavonoids, saponins, etc using 
standard procedures and tests. [3,4] 
Acute toxicity study  
Acute toxicity study – up and down procedure was carried out as per 
the guidelines by Organization for Economic Co-operation and 
Development (OECD) 423. In this experiment three groups of albino 
Swiss mice n=6 were used. [5] Animals were fasted overnight with 
water ad libitum and food was withheld for 3-4 hrs after oral 
administration of the BVEE. First group of animals were treated with 
starting dose of 1000 mg/kg body weight of BVEE orally.  
Second group of animals were treated with a maximum dose of 2000 
mg/kg body weight of BVEE. Control group was treated with normal 
saline. Animals were observed individually after dosing. Observation 
included mortality and gross behaviors e.g. body positions, 
locomotion, rearing, tremors were observed. The effect of BVEE on 
passivity, grip strength, pain response, stereotypy, righting reflex, 
and mortality were assessed. 
Pharmacological evaluation  
Carrageenan - induced paw edema method  
Group 1 (Control): Receive vehicle,  
Group 2 (Test): Ethanolic extract of root of Bauhinia variegata 
(200mg / kg, p.o), 
Group 3 (Test): Ethanolic extract of root of Bauhinia variegata 
(400mg / kg, p.o), 
Group 4 (Standard): Diclofenac sodium (5 mg / kg, p.o) 
Paw oedema was induced by injecting 0.1 mlof 1% carrageenan in 
physiological saline into the subplantar tissues of the left hind paw 
of each rat. [6, 7, 8, 9] The ethanol extracts of Bauhinia variegata 
root (200 & 400 mg/kg) and Diclofenac sodium was administered to 
the groups of group 2, group 3, group 4 orally 30 min prior to 
carrageenan administration. The paw volumes have to be measured 
at 60, 120, 240 minutes by the mercury displacement method 
using a plethysmograph. The percentage inhibition of paw 
volume in drug treated group were compared with the control 
group and standard. 
The Percentage inhibition was calculated by using formula, 
% inhibition = C – T/ C x 100 
C means difference between right and left paw volume in control. 
T means difference between right and left paw volume in test and 
standard, 
Cotton pellet granuloma method  
Group 1 (Control): Receive vehicle, 
Group 2 (Test): Ethanolic extract of Bauhinia variegata root 
(200mg / kg, p.o), 
Group 3 (Test): Ethanolic extract of Bauhinia variegata root 
(400mg / kg, p.o),  
Group 4 (Standard): Diclofenac sodium (5 mg / kg, p.o), 
Cotton pellets weighing 30±1 mg was autoclaved and implanted 
subcutaneously into both sides of the groin region of each rat. The 
ethanol extracts of Bauhinia variegata root at concentration 
200mg/kg, 400mg/kg have to be administered orally for Group 2 
and 3 animals for 7 days. Group IV animals received Diclofenac at a 
dose of 5 mg/kg orally for same period. On 8thday the animals were 
sacrificed and the pellets together with the granuloma tissues were 
carefully removed, dried in an oven at 60oC, weighed and compared 
with control and standard group. 
The Percentage inhibition was calculated by using formula. 
% inhibition = C – T/ C x 100 
C means weight of granuloma in control groups. 
T means weight of granuloma in test and standard groups. 
Statistical analysis  
The results were expressed as Mean ± Standard Error of Mean 
(SEM). [10, 11] The groups were compared by one way analysis of 
variance (ANOVA) followed by post hoc “Dunnett’s Multiple 
comparison test” to analyze statistical significance. P < 0.01 was 
considered to be significant. 
RESULTS 
Phytochemical analysis 
Preliminary phytochemical qualitative analysis of BVEE showed the 
presence of alkaloids, saponins, flavonoids, tannins, phenol 
compounds in the extract. 
Acute toxicity study 
No abnormality in the gross behavioral studies also no mortality 
were noted. Based on these observations two different doses ( 200 
and 400 mg/kg) were selected for the pharmacological studies. 
It predicted that BVEE does not show any marked sign of toxicity 
and mortality up to 1000 mg/kg body weight orally in mice for 24 
hrs and was considered as safe for pharmacological activity. 
According to OECD – 423 guidelines, the LD50
Parameters 
 dose was fixed as 200 
and 400mg/kg. 
 
Table 1: Table showing acute toxicity study 
Group I Group II Group III 
Alertness Normal Normal Normal 
Passive/acute Positive Positive Positive 
Restlessness Absent Absent Absent 
Aggressiveness Absent Absent Absent 
Touch response Normal Normal Normal 
Tremors Absent Absent Absent 
Pain response Normal Normal Normal 
Convulsion Absent Absent Absent 
Righting reflex Positive Positive Positive 
Gripping strength Present Present Present 
Pinna reflex Present Present Present 
Corneal reflex Normal Normal Normal 
Writhing Absent Absent Absent 
Pupils Normal Normal Normal 
Urination Normal Normal Normal 
Salivation Absent Absent Absent 
Skin colour Normal Normal Normal 
Lacrimation Absent Absent Absent 
Respiration Normal Normal Normal 
 
Anti inflammatory activity 
Carrageenan induced paw edema in rats 
Treatment with BVEE at a dose of 200 mg/kg and 400 mg/kg 
exhibited a significant decrease in paw volume. BVEE at 200 & 400 
mg/kg showed significant (p< 0.01) decrease in paw volume at 2nd 
and 4th h. Diclofenac (5 mg/kg) exhibited a significant (p< 0.01) 
reduction in paw volume at 2nd and 4th h as compared to vehicle 
control. The percentage inhibition of change in paw volume of BVEE 
at 200 mg/kg and 400 mg/kg was found to be 20.00% and 33.33 % 
respectively at 2h. However the maximum percentage inhibition was 
found to be at 4th h 23.80% and 38.00 % for 200 mg/kg and 400 
mg/kg of BVEE respectively. The percentage inhibition of Diclofenac 
(5 mg/kg) was found to be 46.60 % and 47.61 % at 2nd & 4th h 
respectively when compared with carrageenan control animal. 
 
 
Table 2: Table showing Carrageenan Induced paw edema Method 
S. No. Treatment Dose Mean edema volume (ml) % Inhibition 
(mg/kg) 1st 2 hr nd 4 hr th 1 hr st 2 hr nd 4 hr th hr 
1 Group 1 1 ml 0.11 ± 0.0063** 0.15±0.0063 0.21±0.0082* - - - 
2 Group 2 200 0.09±5.7490** 0.12±4.2248 0.16±3.0136* 18.18 20.00 23.80 
3 Group 3 400 0.08±6.0707** 0.10±4.2184** 0.13±3.0202** 27.27 33.33 38.00 
4 Group 4 5 0.06±5.7490** 0.08±4.2153** 0.11±4.6837* 45.45 46.60 47.61 
Group 1 – Control, Group 2 - Bauhinia variegata ethanolic extract 200mg, Group 3 - Bauhinia variegata ethanolic extract 400mg, Group 4 - 
Diclofenac sodium , Values are mean ± SEM of 6 parallel measurement. Statistical significant test for comparison was done by ANOVA, followed by 
Dunnet’s ‘t’ test (n=6), All the values are significant **P< 0.01 when compared against control., All the values are significant *
 
Cotton pellet-induced granuloma in rats 
P< 0.01 when compared 
against standard 
The chronic anti-inflammatory activity of the test extract, Diclofenac 
sodium was used as standard control. The percentage decrease in 
the dry weight of granulomatous tissue by the various samples in 
mice was found out and all the values are compared by using t-test. 
Significant reduction in the granulomatous tissue. 
In cotton pellet granuloma, the BVEE (200 and 400 mg/kg) 
significantly (p< 0.01) inhibited the granuloma formation when 
compared to vehicle control group. The degree of inhibition was 
dose dependent. The BVEE at 200, and 400 mg/kg inhibited the 
granuloma formation by 38.44%, and 43.91% respectively. 
Diclofenac (10 mg/kg) significantly (p< 0.01) inhibited the 
granuloma formation by54.76%. 
 
Table 3: Table showing Cotton pellet induced granuloma method 
Treatment Dose (mg/kg) Weight of dry cotton pellet granuloma (mg) % inhibition 
Group 1 1 ml 148.14 ±0.1009 - ** 
Group 2 200 91.19 ±0.0626 38.44 * 
Group 3 400 83.09 ±0.1992 43.91 
Group 4 5 67.01 ±0.0999 54.76 ** 
Group 1 - Control , Group 2 - Bauhinia variegata ethanolic extract 200mg, Group 3 - Bauhinia variegata ethanolic extract 400mg, Group 4 - 
Diclofenac sodium , Values are mean ± SEM of 6 parallel measurement., Statistical significant test for comparison was done by ANOVA, followed by 
Dunnet’s ‘t’ test (n=6), All the values are significant **P< 0.01 when compared against control., All the values are significant *
 
P< 0.01 when compared 
against standard 
DISCUSSION 
The use of traditional medicine is widespread and plants still 
present a large source of structurally novel compounds that might 
serve as leads for development of novel drugs [12]. The present 
investigation was carried out to scientifically evaluate the traditional 
claim of Bauhinia variegata as anti- inflammatory. On acute oral 
toxicity the extract was found to be safe up to 2000 mg/kg. 
Phytochemical screening showed the presence of saponins, phenols, 
flavonoids, alkaloids and tannins. 
Carrageenan induced paw oedema which is a classical model of 
acute inflammation has been widely used in the study of steroid and 
non steroid anti-inflammatory drugs [13]. Carrageenan-induced 
inflammation has a significant predictive value for anti- 
inflammatory agents acting by inhibiting the mediators of acute 
inflammation [14]. Carrageenan is a family of linear sulphated 
polysaccharides extracted from the red seaweed marine alga 
Chondrus crispu. Lambda carrageenan is used in animal models of 
inflammation to test anti-inflammatory activity because dilute 
carrageenan solutions (1-2%) injection causes swelling and pain 
[15]. The edema produced by subplantar injection of carrageenan in 
rat hind paw is biphasic over 4 or more hours. The early phase is 
attributed due to release of serotonin and histamine while later 
phase is sustained by prostaglandins and leucotrienes [16] and 
continuity between two phases is provided by kinins [17]. The 
second phase is sensitive to most clinically effective anti- 
inflammatory drugs. The BVEE was found to significantly inhibit 
carrageenan induced rat paw edema in the late phase regulated by 
prostaglandins and leucotrienes. 
Cotton Pellet induced granuloma in rats is a chronic model of 
inflammation which has been widely used to assess activity of anti-
inflammatory drugs on proliferative phase of inflammation [13]. 
Proliferation of macrophages, neutrophils, fibroblasts and 
multiplication of small blood vessels which are the basic sources of 
highly vascularized reddish mass is termed as granulation tissue is 
seen during repair process of inflammation. The fluid absorbed by 
the pellet greatly influences the wet weight of the granuloma and the 
dry weight correlates well with the amount of granulomatous tissue 
formed [18]. In the present study significant activity of BVEE was 
seen against cotton pellet induced granuloma in rats indicating 
ability of BVEE in reducing number of fibroblasts and synthesis of 
collagen and muco polysaccharide, natural proliferative events of 
granulation tissue formation. The presence of phenolic compounds 
in the extracts may be responsible for the anti -inflammatory 
activities in both the models [19].Therefore anti - inflammatory 
activity of BVEE can be attributed to its phytochemical compounds 
present in the extract. 
CONCLUSION 
BVEE showed anti-inflammatory activity in carrageenan (acute) and 
cotton pellet induced granuloma model (sub acute). This activity can 
be contributed to the phytochemicals present in the extract like 
alkaloids, phenolic compounds, flavanoids and tannins. 
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